| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/2015 | EP2823817A1 New compositions for treating CMT and related disorders |
| 01/14/2015 | EP2823816A1 Inhibitors of Neuropilin and use thereof for the treatment of Neuropilin-related diseases |
| 01/14/2015 | EP2823815A1 Non-aqueous patch |
| 01/14/2015 | EP2823814A1 Pharmaceutical composition for use in medical and veterinary ophthalmology |
| 01/14/2015 | EP2823813A1 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 01/14/2015 | EP2823812A1 Dipeptidylpeptidase IV inhibitors for use in the treatment of Type II diabetes |
| 01/14/2015 | EP2823809A1 Method and apparatus for producing liposomes |
| 01/14/2015 | EP2823043A1 High concentration alpha-glucosidase compositions for the treatment of pompe disease |
| 01/14/2015 | EP2822956A1 Mannose derivatives for treating bacterial infections |
| 01/14/2015 | EP2822953A1 Macrocyclic derivatives for the treatment of proliferative diseases |
| 01/14/2015 | EP2822952A1 Aryl ether-base kinase inhibitors |
| 01/14/2015 | EP2822951A1 Substituted azabicycles and use thereof |
| 01/14/2015 | EP2822950A1 Inhibitors of human immunodeficiency virus replication |
| 01/14/2015 | EP2822949A1 Fused pyrimidines as inhibitors of immunodeficiency virus replication |
| 01/14/2015 | EP2822948A1 Triazolopyrazine derivatives |
| 01/14/2015 | EP2822947A1 Immunologically useful arginine salts |
| 01/14/2015 | EP2822946A1 Thiazole derivatives as alpha 7 nachr modulators |
| 01/14/2015 | EP2822945A1 Aminomethylene pyrazolones with therapeutic activity |
| 01/14/2015 | EP2822944A1 Oxazolidinone compounds and derivatives thereof |
| 01/14/2015 | EP2822943A1 Phosphoinositide 3-kinase inhibitors |
| 01/14/2015 | EP2822942A1 Benzodioxanes for inhibiting leukotriene production |
| 01/14/2015 | EP2822941A1 Benzodioxanes in combination with other actives for inhibiting leukotriene production |
| 01/14/2015 | EP2822940A1 Novel compounds for the treatment of dyslipidemia and related diseases |
| 01/14/2015 | EP2822939A1 Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor |
| 01/14/2015 | EP2822937A1 Pyridinone and pyridazinone derivatives as mch - receptor modulators |
| 01/14/2015 | EP2822936A2 Aminoquinoline derivatives and uses thereof |
| 01/14/2015 | EP2822935A1 Inhibitors of c-jun-n-terminal kinase (jnk) |
| 01/14/2015 | EP2822934A1 Phenicol antibacterials |
| 01/14/2015 | EP2822932A2 Solid state forms of cabazitaxel and processes for preparation thereof |
| 01/14/2015 | EP2822931A1 Triazolone compounds and uses thereof |
| 01/14/2015 | EP2822930A1 Inhibitors of beta-secretase |
| 01/14/2015 | EP2822928A1 Substituted heterocyclic acetamides as kappa opioid receptor (kor) agonists |
| 01/14/2015 | EP2822926A1 Selective histone deactylase 6 inhibitors |
| 01/14/2015 | EP2822922A2 Compounds and uses thereof for treating inflammation and modulating immune responses |
| 01/14/2015 | EP2822656A1 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| 01/14/2015 | EP2822655A1 Compositions and methods of treatment of status epilepticus |
| 01/14/2015 | EP2822646A1 Modulating afferent signals to treat medical conditions |
| 01/14/2015 | EP2822601A1 Micrornas and uses thereof |
| 01/14/2015 | EP2822599A1 Vaccine formulation |
| 01/14/2015 | EP2822598A1 Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof |
| 01/14/2015 | EP2822595A1 Use of sphingosine-1 -phosphate receptors modulators for improving vaccine immunization |
| 01/14/2015 | EP2822586A1 Adjuvanted formulations of streptococcus pneumoniae antigens |
| 01/14/2015 | EP2822561A1 Stable liquid pharmaceutical composition containing piroxicam or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt and the manufacturing method thereof |
| 01/14/2015 | EP2822560A1 Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine |
| 01/14/2015 | EP2822559A1 Imidazo [1, 2 - b]pyridazine - based compounds, compositions comprising them, and uses thereof |
| 01/14/2015 | EP2822558A2 Procaspase 3 activation by combination therapy |
| 01/14/2015 | EP2822557A1 Preparation and use of bicyclic himbacine derivatives as par-receptor antagonists |
| 01/14/2015 | EP2822556A1 Steroid hormone and cholesterol pathways as one unified homestatic system |
| 01/14/2015 | EP2822555A2 Inhibition of adaptor associated kinase 1 for the treatment of pain |
| 01/14/2015 | EP2822554A1 Dosage form comprising lopinavir and ritonavir |
| 01/14/2015 | EP2822553A1 Dosage form comprising non-crystalline lopinavir and crystalline ritonavir |
| 01/14/2015 | EP2822552A2 Improved method and compound for treatment of menopausal symptoms |
| 01/14/2015 | EP2822551A1 Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria |
| 01/14/2015 | EP2822550A1 Composition and methods to enhance anti-oxidation, gut flora and immunity in pets |
| 01/14/2015 | EP2822549A1 Dialysis composition comprising citrate, calcium and magnesium |
| 01/14/2015 | EP2822548A1 Long chain base sphingosine kinase inhibitors |
| 01/14/2015 | EP2822547A1 Gynecologic composition to treat vulvar vestibulitis |
| 01/14/2015 | EP2822546A1 Procaspase combination therapy for glioblastoma |
| 01/14/2015 | EP2822545A2 Treatment for high cholesterol |
| 01/14/2015 | EP2822544A1 Pharmaceutical compositions comprising metformin and a dpp -4 inhibitor or a sglt-2 inhibitor |
| 01/14/2015 | EP2822542A1 Controlled-release solid dosage forms of mesalamine |
| 01/14/2015 | EP2822541A1 Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof |
| 01/14/2015 | EP2822539A2 Nanocrystalline solid dispersion compositions and process of preparation thereof |
| 01/14/2015 | EP2822537A1 Combination therapy agent for treating rhinitis |
| 01/14/2015 | EP2822535A1 Improved stability of hydromorphone hydrochloride solutions |
| 01/14/2015 | EP2822405A1 Dietary supplement |
| 01/14/2015 | EP2822403A1 Methods for enhancing, improving, or increasing fertility or reproductive function |
| 01/14/2015 | EP2822402A1 Liquid nutritional composition comprising free amino acids |
| 01/14/2015 | EP2822396A1 Animal feed composition containing encapsulated glucono delta-lactone |
| 01/14/2015 | EP2822395A1 Dietary supplement for pet mammals |
| 01/14/2015 | EP2822383A1 Antimicrobial compostion containing lauric acid and method for their production |
| 01/14/2015 | DE202012013111U1 Eine Kombination aus mindestens zwei dirkt wirkenden antiviralen Wirkstoffen zur Verwendung in der Behandlung von HCV A combination of at least two dirkt acting antiviral agents for use in the treatment of HCV |
| 01/14/2015 | CN204092615U 一种止痛敷贴 One analgesic applicator |
| 01/14/2015 | CN204092614U 盐酸克林霉素异形片 Clindamycin Hydrochloride shaped pieces |
| 01/14/2015 | CN204092613U 替米沙坦异形片 Telmisartan shaped piece |
| 01/14/2015 | CN104284899A 三环化合物和其应用方法 Tricyclic compounds and their application methods |
| 01/14/2015 | CN104284896A 取代的咪唑并哒嗪 Substituted imidazopyridazine |
| 01/14/2015 | CN104284895A 含氮双环式芳香族杂环化合物 Bicyclic aromatic nitrogen-containing heterocyclic compounds |
| 01/14/2015 | CN104284894A 新型吡唑化合物 Novel pyrazole compound |
| 01/14/2015 | CN104284893A 用于治疗皮肤疾病、病症以及病状的肝x受体(lxr)调节剂 For the treatment of skin diseases, liver diseases and pathologies x receptor (lxr) modulators |
| 01/14/2015 | CN104284891A 构象受限的全合成大环化合物 The total synthesis of conformationally constrained macrocyclic compounds |
| 01/14/2015 | CN104284887A 作为alx受体激动剂的经1-(对-甲苯基)环丙基取代的桥联螺[2.4]庚烷衍生物 Bridging Lo - (toluene-p) ring-substituted propyl [2.4] heptane derivatives as alx receptor agonists by 1- |
| 01/14/2015 | CN104284885A 莱菔硫烷衍生的化合物、其制备方法及其医疗、食品和化妆品用途 Compound sulforaphane derived, their preparation and their medical care, food and cosmetic use |
| 01/14/2015 | CN104284884A 氟取代的(3r,4r,5s)-5-胍基-4-乙酰氨基-3-(戊烷-3-基氧基)环己烯-1-甲酸、它们的酯及它们的应用 Fluoro-substituted (3r, 4r, 5s) -5- guanidino-4-acetylamino-3- (pentan-3-yloxy) cyclohexene-1-carboxylic acid, their esters and their applications |
| 01/14/2015 | CN104284671A 使用阿拉泊韦的药代动力学调节 Use Allah parked Wei pharmacokinetic adjustment |
| 01/14/2015 | CN104284668A 用于治疗神经变性疾病的天竺葵精油及其成分 For the treatment of neurodegenerative diseases, geranium oil and components |
| 01/14/2015 | CN104284667A 采用化学修饰的肝素或硫酸乙酰肝素和子宫收缩剂的产后出血的治疗 Chemically modified heparin or heparan sulfate and uterotonic postpartum hemorrhage |
| 01/14/2015 | CN104284666A 肠内环境改善剂 Intestinal environment improving agent |
| 01/14/2015 | CN104284665A 吡唑衍生物及其医药用途 Pyrazole derivatives and pharmaceutical use |
| 01/14/2015 | CN104284664A 广谱抗生素Arylomycin类似物 Broad-spectrum antibiotics like Arylomycin |
| 01/14/2015 | CN104284663A 高剂量拉喹莫德(laquinimod)用于治疗多发性硬化症的用途 Use of high-dose pull quinoline Maude (laquinimod) for the treatment of multiple sclerosis |
| 01/14/2015 | CN104284662A 晶体及包含该晶体的药物制剂 Crystal and pharmaceutical preparations containing the crystals |
| 01/14/2015 | CN104284661A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并-[3,4,b]吲哚]-4-胺和水杨酸组分的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol furans and - [3,4, b] indole] -4-amine and pharmaceutical compositions of the salicylic acid component |
| 01/14/2015 | CN104284660A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并[3,4,b]吲哚]-4-胺和NSAR的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol pyrano [3,4, b] indole] -4-amine and pharmaceutical compositions NSAR |
| 01/14/2015 | CN104284659A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并-[3,4,b]吲哚]-4-胺和丙酸衍生物的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol furans and - [3,4, b] indole] -4-amine and pharmaceutical compositions of the propionic acid derivative |
| 01/14/2015 | CN104284658A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并[3,4,b]吲哚]-4-胺和加巴喷丁类的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol pyrano [3,4, b] indole] -4-amine and gabapentin pharmaceutical composition class D |
| 01/14/2015 | CN104284657A 用于抑制RORγ活性和治疗疾病的双环砜化合物 Bicyclic sulfone compounds for the inhibition and treatment of disease activity RORγ |
| 01/14/2015 | CN104284656A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并[3,4,b]吲哚]-4-胺和抗惊厥剂的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol pyrano [3,4, b] indole] -4-amine and anticonvulsant pharmaceutical composition |
| 01/14/2015 | CN104284655A 治疗乳糖不耐受的方法 Method for treating lactose intolerance |
| 01/14/2015 | CN104284602A 包含游离氨基酸的液体营养组合物 Liquid nutritional composition comprising free amino acids |